Workflow optimization, increased efficiency and reduced errors in clinical trials

"It's a paradigm shift." This is how Prof. Ulf Teichgräber, Director of the Institute of Diagnostic and Interventional Radiology at the University Hospital Jena, describes the improvement in communication with sponsors and CROs through the use of mint Lesion™. Together, Ms. Laura Graziani, study coordinator, Ms. Elisabeth Lammers, study assistant/MTRA, and Prof. Teichgräber describe their journey towards a successful clinical trial center that can now manage up to 40 clinical trials simultaneously.
 
Where results previously had to be painstakingly entered into Excel spreadsheets, mint Lesion™ has taken over the evaluation of all findings since its introduction in 2015, thus increasing the objectivity and validity of the study results.

Click here or on the image above to watch the full video on YouTube.

Related Resources

Related Resources

A radiologist reviewing the updated PCWG4 prostate cancer clinical trial guidelines.

From PCWG3 to PCWG4: Evolving Standards in Prostate Cancer Clinical Trials

The Prostate Cancer Working Group 4 (PCWG4) updates and extends the recommendations of PCWG3 to reflect a patient-centric approach, the emergence of…

Group photo of Mint Medical and mediaire team

Mint Medical and mediaire strengthen the prostate cancer care pathway with AI-Powered MRI Solutions

Mint Medical, a Snke company, and mediaire announce a collaboration to advance AI‑powered MRI workflows through the interoperability of mint Lesion…

Postoperative brain tumor MRI comparing TGSE-BLADE and RESOLVE DWI showing distortion reduction near resection site

Improving Postoperative Brain Tumor MRI: TGSE-BLADE vs. RESOLVE DWI

Early MRI scans are critical for patients who have just undergone brain tumor resection to evaluate the surgery's success and plan future treatments.…